NFKB1 and breast carcinoma: DIM is a natural small-molecule anti-cancer drug that has been shown to inhibit cell proliferation and induce cell apoptosis in prostate and breast cancer cells through the regulation of the Akt/FOXO3a/GSK-3/β-catenin/AR signaling axis (18) and reduction of NF-κB activity (19).